The Global Response to Ebola: Implications for Future Drug & Vaccine Development The Ebola epidemic, which tore through West Africa in 2014, and continues to pose a huge global health challenge, has prompted unparalleled collaboration between worldwide academia, industry and government. This has led to the development and trialling of new vaccine candidates at rates unprecedented in the pharmaceutical industry. Join us for what is certain to be an informative and enthralling discussion about how entrepreneurs, academics, industry professionals and governments can learn lessons from the collaborative approach used to fight Ebola, and how this can lead to revolutionary new approaches in drug discovery & development. Exclusive Speakers: • Dr W. Shawn Carbonell CEO & Cofounder, OncoSynergy Inc. • Prof. Miles Carroll Head of Research & Microbiology Services, Public Health England • Prof. Dame Sally Davies Chief Medical Officer for England, Chief Scientific Advisor to the Department of Health, NHS England • Dr Adam Hacker VP Global Regulatory Affairs & Ebola Project Oversight Leader, Janssen Pharmaceuticals Johnson&Johnson • Prof. Adrian Hill Oxford Ebola Clinical Trial Group Leader and Director, The Jenner Institute, University of Oxford • Dr Marguerite Koutsoukos Ebola & HIV Project Oversight Leader, GlaxoSmithKline Join us for our wine reception and networking session. After the event there will be an exclusive chance to engage with our speakers and sponsors in a less formal setting. Attendance is FREE to all, and tickets are guaranteed to sell out once they are released! Get your ticket now! -Oxford Biotech For details, link here: https://www.eventbrite.co.uk/e/oxford-biotech-the-global-response-to-ebola-tickets-16690476665

Get in touch

4 + 13 =

Copyright © 2020 Enterprising Oxford | Site by Herd